The Discounted Cash Flow (DCF) valuation of Sun Pharma Advanced Research Co Ltd (SPARC.NS) is (86,933,625,046.22) INR. With the latest stock price at 161.42 INR, the upside of Sun Pharma Advanced Research Co Ltd based on DCF is -53855547768.3%.
Based on the latest price of 161.42 INR and our DCF valuation, Sun Pharma Advanced Research Co Ltd (SPARC.NS) is a sell. selling SPARC.NS stocks now will result in a potential gain of 53855547768.3%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 11.2% - 16.1% | 13.6% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (140,025,733,203.92) - (61,900,851,213.66) | (86,933,625,046.22) |
| Upside | -86746210733.1% - -38347696304.7% | -53855547768.3% |